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a  b  s  t  r  a  c  t
The  highly  anionic  synthetic  pentasaccharide  fondaparinux  (FDPX)  – representing  the  antithrombin  bind-
ing sequence  of  heparin  –  is  in  clinical  use  as a potent  anticoagulant.  Contrary  to  the  unfractionated
heparin, FDPX  lacks  potent  antidote  completely  reversing  its  anticoagulant  activity,  therefore  it  is of
great  importance  to  identify  new  structures  exhibiting  strong  intermolecular  interactions  towards  FDPX.
The  polycationic  heptakis(6-amino-6-deoxy)-beta-cyclodextrin  (NH2--CD)  can  serve as an  excellent
model  compound  to mimic  these  interactions  between  the  oppositely  charged  oligosaccharides.  Herein,
extensive  NMR  spectroscopic  and  nano-electrospray  ionization  mass  spectrometric  (nESI-MS)  studies
were  conducted  to understand  the  molecular-level  interactions  in  the  FDPX  - NH2--CD systems.  NMR
experiments  were  performed  at  pD  7.4 and  2.0.  Job’s  method  of  continuous  variation  and 1H  NMR titra-
tion  experiments  suggested  the  formation  of  FDPX·NH2--CD complex  at pD  7.4,  while  the presence  of
multiple  complexes  was  assumed  at pD 2.0.  Stability  constants  were  determined  by separate 1H NMR
titrations,  yielding  log ˇ11=3.65  ±  0.02  at pD 7.4,  while  log  ˇ11 ≥  4.9 value  suggested  a high-affinity
system  at  pD 2.0. 2D  NOESY  NMR studies  indicated  spatial  proximities  between  the anomeric  resonance
-l-iduronic  acid  residue  and  the  cyclodextrin’s  methylene  unit  in  the  proximity  of the  cationic  amino
function.  Acidic  degradation  of  FDPX  was  investigated  by  NMR  and  MS for the  first  time  in detail  confirm-
ing  that  desulfation  occurs  involving  one  to two  sulfate  moieties.  The  desulfation  of  FDPX  was  inhibited  by
the cationic  cyclodextrin  in the  case  of  equimolar  ratio at pD  2.0. This  is the first  report  on  the  stabilizing
effect  of  cyclodextrin  complexation  on heparin  degradation.










Heparin is an anionic, linear polysaccharide, a member of the
glycosaminoglycan (GAG) family that is naturally synthesized and
stored in mast cells [1]. Although the core structure of heparin
consists of repeating 1,4-linked uronic acid and glucosamine dis-
accharides, it has a microheterogenous and polydisperse structure
due to various modification of the monosaccharide subunits. The
hexuronic acid is either -l-iduronic acid (IdoA) or -d-glucuronic
acid (GlcA), which may  be 2-O-sulfated. The hexosamine residue
is d-glucosamine (GlcN), which may  be sulfated at the 3-O  and 6-
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 positions and N-sulfated (GlcNS), N-acetylated (GlcNAc) or may
e unmodified as a primary amine [2]. Heparin is best known
or its anticoagulant activity, exerted through the interaction with
he protease inhibitor antithrombin-III (AT-III). AT-III is the major
lasma coagulation inhibitor, whose main targets are IIa and Xa
ctivated coagulation factors [3]. Heparin is a widely used anticoag-
lant drug in the clinical practice despite its numerous undesirable
ide effects.
Nowadays, low molecular weight heparins (LMWHs) are applied
n the clinical practice as an anticoagulant agent due to their pre-
ictable activity profile, better bioavailability and longer half-life,
hat contribute to their safer applicability. LMWHs  are pre-
ared from unfractionated heparin by chemical or enzymatic
epolymerization reactions that produce polydisperse mixtures of
eparin-derived oligosaccharides [4].
 under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
























Fig. 1. Chemical structures and numbering of the fondaparin
Another alternative in heparin-based anticoagulant therapy
is the synthetic pentasaccharide fondaparinux (FDPX). It was
designed to mimic  the heparin pentasaccharide sequence present
in each heparin derivative and required to bind AT-III, thus enhanc-
ing its inhibitory activity toward factor Xa [5]. FDPX is a methyl
glucoside analogue of the heparin pentasaccharide sequence
responsible for AT-III binding (Fig. 1). To neutralize the anticoag-
ulant effect of heparin, protamine sulfate is usually used in the
clinical practice. It is a basic, polycationic peptide isolated from
salmon sperm, which binds to the polyanionic heparin through
electrostatic interactions, thus forming an inactive complex with-
out anticoagulant effect [6]. Unfortunately, protamine is unable
to reverse the anticoagulant function of LMWHs  and is even less
effective for fondaparinux. Therefore, it is necessary to find new
antidotes, which should be effective for all heparin derivatives [7].
Among the possible core structures as future antidotes, modified
carbohydrates and cyclodextrins stand out as promising candidates
[8].
Cyclodextrins are cyclic oligosaccharides built of d-
glucopyranose units linked via -1,4-glycosidic bonds. As a
result, they have a truncated cone shape with a lipophilic inner
cavity and a hydrophilic outer surface [9]. This particular struc-
ture enables reversible inclusion complex formation with guest
molecules with appropriate properties [10]. Interactions between
the cyclodextrin host and the guest molecules are generally
noncovalent: hydrogen bonds, van der Waals and hydrophobic
interactions are common, while in case of ionic derivatives elec-
trostatic interactions dominate. The most commonly used native
cyclodextrins are the -, - and -cyclodextrin composed of six,
seven and eight glucose units, respectively. Synthetic modification
of the hydroxyl groups of the glucopyranose units offers numerous
possibilities for the preparation of various cyclodextrins, such as







) and the heptakis(6-amino-6-deoxy)-beta-cyclodextrin (B).
tilized (Fig. 1). These chemical modifications are often aimed at
roviding structure-specific interactions, thereby contributing to
n even more pronounced supramolecular assembly [11,12].
The current study aims to characterize the molecular inter-
ctions between the polyanionic FDPX and the polycationic
yclodextrin NH2--CD as a potential heparin antidote. Further-
ore, the stabilizing effect of the NH2--CD (hereinafter denoted
s CD) on FDPX degradation under acidic conditions was also
nvestigated. To establish a more profound understanding of the
ntermolecular interaction as well as the degradation of FDPX under
cidic conditions, extensive NMR  and MS  experiments were per-
ormed.
. Materials and methods
.1. Chemicals and reagents
CD was  a product of CycloLab Ltd. (Budapest, Hungary). D2O
99.9 atom% D) was purchased from Merck (Darmstadt, Germany),
hile fondaparinux was  isolated from Arixtra® 2.5 mg/0.5 mL  injec-
ions. Briefly, ten prefilled injections were combined and subjected
o dialysis (Spectra/Por® dialysis membrane – Biotech- CE Tubing
WCO: 100−500 Da) against deionized water for three consecu-
ive days. Thereafter, the dialysate was subjected to freeze-drying.
ther base chemicals of analytical grade were purchased from com-
ercial suppliers and were used without further purification.
.2. NMR spectroscopy
Nuclear magnetic resonance (NMR) spectroscopy measure-
ents were carried out on a 600 MHz  Varian DDR NMR
pectrometer (Agilent Technologies, Palo Alto, CA, USA), equipped
ith a 5 mm inverse-detection probehead and gradient unit. Stan-
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3.2C/Chempack 5.1 were used. The complete resonance assign-
ments of the fondaparinux and the CD were established from
direct 1H–13C, long-range 1H–13C, and scalar spin-spin connectiv-
ities derived from 1D 1H, 2D 1H-1H gCOSY, zTOCSY (mixing time
of 150 ms), ROESYAD (mixing time of 400 ms), NOESY and 1H–13C
gHSQCAD (J =140 Hz – according to the one bond heteronuclear
coupling constant) experiments. The 1H chemical shifts were ref-
erenced to the methyl singlet (ı =3.31 ppm) of internal CH3OH, a
reference substance without any possible interaction with the CD.
Additional NMR  studies were performed on an 800 MHz Bruker
Avance III HDX800 MHz  spectrometer equipped with a 5 mm
1H/13C/15N Triple Resonance 13C Enhanced Salt Tolerant Cold Probe
(1H: 799.7 MHz, 13C: 201.0 MHz), controlled by the TopSpin 3.5 pl 7
software (Bruker Biospin GmbH, Rheinstetten, Germany). All NMR
spectra were acquired in standard 5 mm NMR  tubes at 25 ◦C.
2.2.1. 1H NMR  titration experiments
The stoichiometry of FDPX complexation with CD was investi-
gated by the Job’s method of continuous variation [13]. Samples
were prepared in 0.1 M phosphate buffers of pD 2.0 and pD 7.4, at
25 ◦C temperature. The total molar concentration of the two com-
ponents, cFDPX + cCD was  kept constant at 3 mM,  while the mole
fraction of FDPX, xFDPX = cFDPX/(cFDPX + cCD) was varied gradually in
0.1 unit steps from 0 to 1. 1H chemical shifts ıFDPX were recorded at
600 MHz  for several FDPX protons and complexation-induced dis-




∣ were calculated with
respect to ıFDPX measured in the absence of CD. To construct Job’s
plots, ıFDPX values were multiplied by the mole fraction of FDPX
and depicted as a function of xFDPX. Analogous plots were generated
for selected protons of the CD.
Since the experimental design underlying Job’s plots may  not
be optimal to determine the stability constants of the formed com-
plexes [14], separate NMR  titrations were performed under the
same experimental conditions as used for the Job’s plot. At pD 7.4,
increasing portions ranging from 20 to 280 L of 20.1 mM CD solu-
tion were added to 600 L of 3.4 mM FDPX solution residing in
the NMR  tube. At pD 2.0, 600 L of 3.18 mM FDPX solution was
titrated with 10–250 L of 20.9 mM CD stock solution. Follow-
ing equilibration, 1H NMR  spectra were recorded in each titration
step at 600 MHz  and 25 ◦C temperature. The experimental titra-
tion curves for well-resolved resonances of FDPX and CD were
evaluated by the OPIUM software [15] according to the principles
summarized here by assuming the formation of both FDPX·CD and
FDPX·2CD complexes as a general case. If complexation occurs with
rapid kinetics on the NMR  chemical shift timescale, the observed
chemical shift ıFDPX,i of any carbon-bound proton in FDPX becomes
a mole-fraction weighted average [14] of the species-specific val-
ues in the uncomplexed FDPX (ıiFDPX) and those in the complexes
(ıiFDPX · CD and ı
i
FDPX ·  2CD),
ıFDPX,i = [
FDPX] ıiFDPX + [FDPX · CD] ıiFDPX·CD + [FDPX · 2CD] ıiFDPX·2CD
cFDPX
(1)
where square brackets denote equilibrium concentrations and i
used herein is a running index. Analogously defined intrinsic chem-




FDPX·2CD) and resonance signal averaging
apply for any carbon-bound proton of the cyclodextrin:
ıCD,j = [
CD] ıjCD + [FDPX · CD] ı
j





where square brackets denote equilibrium concentrations and j
used herein is a running index. The mass-balance equations for both
constituents read:
cFDPX = [FDPX] + [FDPX · CD] + [FDPX · 2CD] (3)






Journal of Pharmaceutical and Biomedical Analysis 197 (2021) 113947
hich can be reformulated in terms of the  ̌ association (i.e. binding
r formation) constants of the complexes, yielding:
FDPX = [FDPX] (1 + ˇ11 [CD] + ˇ12[CD]2) (5)
CD = [CD] (1 + ˇ11 [FDPX] + 2ˇ12 [FDPX] [CD]) (6)
Based on the input values of cFDPX and cCD for each titration point
the ratio of which was checked from non-overlapping 1H NMR
ntegrals of the components) as well as initial guesses of the  ̌ sta-
ility constants, the OPIUM program solved the nonlinear system of
qs. (5) and (6) for the variables [FDPX] and [CD]. These speciation
alculations were integrated into a least-squares fitting procedure
f Eqs. (1) or (2) to the measured dataset in order to iteratively
efine the stability constant(s). Since the OPIUM program lacks a
raphical output, the resulting equilibrium constants were used
o compute species distribution data covering the 0–2.7 4 interval
f the cCDcFDPX ratio by the ORCHESTRA program [16]. These datasets
ere subsequently imported into Microsoft Excel 2002, where Eqs.
1) and (2) were used to calculate and depict the continuous curves
tted to the experimental 1H NMR  titration datasets.
.2.2. NMR structural studies on complex formation
To explore the spatial arrangement of the host-guest complexes
nd identify the interacting molecular sequences, nuclear Over-
auser effect (NOE) type experiments were performed at cCD =
FDPX =1 mM in unbuffered samples at different pD values (2.0–7.4)
o eliminate the possible interfering effect of the phosphate ions.
OE is a manifestation of dipolar cross relaxation between two
onequivalent nuclear spins that are close enough (<5 Å) through
pace [17]. The NOE intensities are scaled with r−6, where r repre-
ents the mean distance between the protons. 2D NOESY spectra
ere acquired on the 600 MHz  instrument, with mixing times of
00 ms  using 16 scans on 1258 × 512 data points. For the acidic
ample, 2D NOESY spectra were also recorded on the 800 MHz
nstrument, collecting 24 scans on 4096 × 512 data points, applying
ixing times of 350 ms,  400 ms,  500 ms  and 650 ms along with a
50-W presaturation on the HDO signal for D1  = 2.5 s.
.2.3. NMR investigations of FDPX degradation
To determine the structure of the FDPX decomposition product,
H and several 2D (COSY, TOCSY, HSQC, ROESY) NMR  spectra were
ecorded at 600 MHz  with the same parameters described in chap-
er 2.2. For this experiment, 5 mM FDPX was dissolved in a 0.1 M
hosphate buffered D2O at pD 2.0.
During the stability investigation, FDPX:CD samples with 1:0,
:1 and 1:1 molar ratios were tested. All samples were dissolved in
.1 M phosphate buffered D2O at pD 2.0. In the case of the first set of
xperiments, 1H NMR  spectra of the freshly prepared samples were
ecorded. After keeping these samples at 25 ◦C for a week, their
H NMR  spectra were recorded again. A second experiment was
arried out to perform an accelerated decomposition investigation.
H NMR  spectra of the fresh samples were recorded at 25 ◦C, then
amples were incubated at 60 ◦C for 14 h. Afterwards all samples
ere cooled down to 25 ◦C again and 1H spectra were re-recorded.
.3. Electrospray ionization mass spectrometry
Mass spectrometric measurements were performed in negative
on mode on a modified Synapt G2-S HDMS Q-IMS-ToF hybrid mass
pectrometer (Waters Co., Manchester, UK), equipped with a nano-
lectrospray ion (nESI) source and an rf-confining drift cell (250.5
m in length). An MKS  647C multichannel controller (MKS Instru-
ents, Andover, Massachusetts, US) provided gas flow and pressure
ontrol in the drift cell, which was  filled with He buffer gas (99.999%
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For studying the complex formation between FDPX and CD,
the compounds were dissolved in water:methanol (50/50, v/v) to
reach a concentration of 20 M for FDPX and 200 M for CD. The
solvent mixture was prepared using Milli-Q® water and LC–MS
grade methanol (Merck, Darmstadt, Germany). For MS  experiments
involving the FDPX degradation products, 5 mM FDPX was dis-
solved in a 0.1 M phosphate buffered D2O at pD 2.0 and incubated
at 60 ◦C for 14 h, identically to the solution used for NMR  spectro-
scopic degradation measurements (see Section 2.2.3). This acidic
solution was diluted in water:methanol (50/50) and spiked with a
10 mM aqueous solution of CD to reach a concentration of 20 M
for FDPX degradation products (calculated for the pre-incubation
FDPX content) and 200 M for CD.
For generating negative ions using nESI, 5 L of the sam-
ple solutions described above was loaded into in-house prepared
borosilicate needles coated with Pt/Pd (80/20), and a voltage of -
0.60 to -0.85 kV was applied to the capillary. Typical instrument
settings of the Synapt G2-S HDMS instrument were as follows:
capillary voltage -0.60 to -0.85 kV; source temperature 100 ◦C; sam-
pling cone 2.0; source offset 0.0; trap gas flow 2.0 mL  min−1; trap
DC entrance 4.0; trap DC bias 2.0; trap DC −2.0; trap DC exit 1.0;
IMS  DC entrance −23.0; helium cell DC 55.0; IMS  bias 45.0; helium
exit −40.0; IMS  DC exit 5.0; transfer DC entrance 5.0; transfer DC
exit 15.0; trap wave velocity 250 m s−1; trap wave height 0.8 V;
transfer wave velocity 300 m s−1; transfer wave height 4.0 V. All
mass spectra were recorded in resolution mode. For clarity, polar-
ities and units of the values above are provided as displayed in the
MassLynx 4.1 software package (Waters Co., Manchester, UK). As
such, some voltages are given only with numerical values with no
unit specified.
Data processing and analysis were performed using MassL-
ynx 4.1 (Waters Co., Manchester, UK) and Origin 2017 (OriginLab,
Northampton, MA,  US) software packages.
3. Results and discussion
3.1. Exploring the complex formation equilibria by NMR  titrations
Intermolecular interactions between FDPX and CD were investi-
gated at two different pD values (pD 2.0 and 7.4), where the charge
distribution of the interacting species is different. At the physiolog-
ical pD value, the CD derivative bears an average positive charge of
5.1 (pKa values for the CD are as follows: 9.50(1), 8.89(1), 8.33(1),
8.07(1), 7.57(1), 7.35(1), 6.75(1) [18]), while at pD 2.0 the host is
fully protonated, carrying seven positive charges. In the case of
FDPX according to the published related oligosaccharides the pKa
values are 2.35 and 3.44 for -d-GlcA and IdoA2S [19], thus at pD
7.4 both hexuronic acid residues are deprotonated, therefore FDPX
possesses 10 negative charges. Under acidic conditions (pD 2.0),
the mean charge of FDPX corresponds to −8.3. Complete 1H NMR
assignments of FDPX and CD at pD 2.0 and 7.4 can be found in Table
S1 of Supporting Information.
In order to assess the complexation stoichiometry at pD 7.4, Job’s
plots were constructed from well-separated NMR  signals of FDPX,
such as those of the anomeric protons of the GlcNS6S, GlcA and
GlcNS3S6S residues, the H1 and H5 resonances of IdoA2S, and the
anomeric H1 resonance of the CD. All the Job’s plot curves depicted
on A and B diagrams in Fig. 2 show a maximum at xFDPX = 0.5,
suggesting the sole formation of the FDPX·CD complex with 1:1
stoichiometry.
During the subsequent single-tube NMR  titration of FDPX with
CD at the same pD value (see the stack plot in Fig. 3A), the chem-
ical shift variation of the following protons with non-overlapping
signals were monitored: GlcA H1, GlcNS3S6S H1, GlcNS6S-OMe H1,
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D derivative. Titration profiles of the latter two nuclei are depicted
n Fig. 3B, while those of the remaining FDPX protons listed above
re shown in Fig. S1. All the eight datasets could be adequately fit-
ed using the OPIUM program by assuming only the single FDPX·CD
omplex, as suggested by the Job’s plots. These evaluations yielded
stimates for the binding constant log ˇ11 ranging from 3.25 to 4.3,
ollected in Table S2. In order to extract a more robust and reliable,
ingle value of this stability constant [20], the eight datasets were
ubjected to simultaneous nonlinear regression using the same
oftware. The quality of fit remained virtually the same for all the
bserved nuclei and this global evaluation yielded log ˇ11 = 3.65
ith an estimated standard deviation of 0.02, a moderately strong
inding affinity for a CD complex (see the species distribution plot
n Fig. S2). The complexation-induced changes in chemical shifts
xceeded 0.04 ppm units for the GlcNS3S6S H5, IdoA2S H1 and H5
rotons of FDPX, the intrinsic chemical shifts (listed in Table S3)
merging from the global data fitting only slightly differed from
heir counterparts from single-dataset evaluations in Table S2.
The Job’s plots recorded at pD 2.0 revealed a less clear-cut pic-
ure about complexation (see Fig. 2, subplot C and D). While the
rofile of the anomeric CD proton in subplot D is rather wide but
ears a maximum at xCD = 0.5, suggesting again a simple 1:1 com-
lexation pattern, the extremum of each FDPX proton’s profile in
ig. 2, subplot C is consequently shifted to ca. xFDPX = 0.6, indicating
he presence of a 2FDPX·CD complex besides FDPX·CD.
To explore the complexation equilibria at pD 2.0 more thor-
ughly, a single-tube 1H NMR  titration of FDPX with the CD was
arried out (see the stack plot in Fig. S3). Titration profiles of the
nomeric protons belonging to the GlcNS6S and GlcNS3S6S units
re depicted in Fig. 4, while those for four additional protons of
DPX as well as for the CD anomeric proton are shown in Fig. S4.
ost titration profiles of FDPX protons consist of two  quasi lin-
ar segments, with a minimal curvature near the crossing point at
CD = cFDPX. This type of titration curve is characteristic to a rather
igh-affinity system, for which merely the lower limit of the bind-
ng constant is accessible by curve-fitting [14]. The entire dataset
annot be fitted satisfyingly assuming the formation of a single
DPX·CD complex (see the blue curves in Fig. 4 and Fig. S4), the
amilton’s R factor, a goodness-of-fit criterion for the simultaneous
tting of the seven datasets, is 0.031%. The intrinsic chemical shifts
re listed in Table S4. Hence the titration curves were evaluated in
wo steps.
All experimental datasets can be nicely fitted up to cCDcFDPX = 1 with
he assumption of a single FDPX·CD complex only (blue curves in
ig. 4 and Fig. S4), yielding log ˇ11 = 4.9 ± 0.1, but higher values
f this stability constant give virtually the same goodness-of-fit.
ddition of a 2FDPX·CD species to the equilibrium model, as sug-
ested by Job’s plots, did not furnish a meaningful value for ˇ21,
he iterations by the OPIUM program did not converge. Intuitively,
ne cannot describe the monotonic change in FDPX chemical shifts
eyond the equimolar composition by the {FDPX·CD,  2FDPX·CD}
quilibrium model. Instead, an FDPX·2CD complex was  postulated
esides FDPX·CD. A global fitting involving these two species was
lready able to describe the titration profiles of FDPX and CD pro-
ons in the full range of concentrations studied (see the fitted red
urves in Figs. 4 and S4), the Hamilton’s R factor decreased to
.0089%, indicating a more appropriate equilibrium model. The cal-
ulations yielded a stability constant of log ˇ12 = 8 for the FDPX·2CD
omplex (but this value again represents merely a lower limit).
he intrinsic chemical shift values of species are collected in Table
5. Using these lower limits of the stability constants, the specia-
ion curves in Fig. S5 were constructed for the concentration range
xplored in the NMR  titration.
The discrepancy of Job’s method and the chemical shift titra-
ion in establishing the correct stoichiometry of complexation is






















Fig. 2. Job’s plot for the selected 1H resonances of FDPX at pD 7.4 (A) and at pD 2
respectively.
somewhat puzzling. Nevertheless, recent publications [21] [22]
emphasize the limitations of Job’s method of equilibrium systems
beyond the simplest 1:1 case, being highly sensitive e.g. to the ratio
of equilibrium constants [21]. While Job’s method remains a reli-
able tool in stoichiometric studies of inorganic metal complexes,
a careful inspection of the distribution of residuals of data-fitting
[20,21] or the ranking of all reasonable binding models accord-
ing to estimated uncertainties and other chemometric descriptors
[22] became the recommended protocols for the same task in the
field of supramolecular chemistry. Since the {FDPX·CD, FDPX·2CD}
equilibrium model nicely reproduced the entire titration dataset,
the formation of these two species can be regarded as most proba-
ble under the applied experimental conditions for this high-affinity
system.
3.1.1. NMR  structural studies
To obtain atomic-level information about the 3D structure of
the FDPX-CD complex, NOE experiments were carried out for sam-
ples without phosphate buffer, to eliminate any possible interfering
effect of the phosphate ions with the CD. Solutions at pD 2.0–7.4
were tested. The 2D NOESY spectrum for all pD values revealed
that the H6 protons of the CD give intermolecular contacts with the
FDPX’s IdoA2S H1 proton – as shown in Fig. 5 for the pD 2.0 sam-
ple. NOE experiments were performed at several FDPX:CD molar
ratios, however, none of the experiments confirmed dipolar corre-






and that of the anomeric resonance of NH2--CD at pD 7.4 (B) and at pD 2.0 (D),
uter-sphere, electrostatics-driven complex formation can occur
etween these oligosaccharides as also found in a recent study [23].
.1.2. NMR investigations of FDPX degradation
It is well known from the literature, that sulfated polysaccha-
ides can undergo degradation (depolymerization and desulfation)
nder acidic conditions. However, there are no detailed studies
hat provide relevant information on FDPX. Recording the 1H NMR
pectra of aqueous FDPX sample at pD 2.0 after a week of stor-
ge indicated that new 1H resonances appeared, see Fig. 6. In order
o identify the structure of the degradation product, additional 2D
pectra were recorded. The spin system of the monosaccharide sub-
nits of the degradation product was identified by COSY and TOCSY
xperiments, respectively. 1H–13C HSQC experiment evidenced
hat the anomeric carbon of the GlcNS3S6S unit (ı =6 ppm) and
he C5 resonance of the IdoA2S moiety (ı  = 2 ppm) exhibited
emarkable shifts compared to the intact FDPX (Fig. S6). A 2D ROESY
xperiment (Fig. S7) was performed to establish the connectivity
f the monosaccharides. Based on the ROESY data the pentasac-
haride chain remained intact during the applied circumstances of
egradation. Therefore, the observed chemical shift changes upon
ecomposition (Fig. S8) cannot be attributed to the depolymeriza-
ion of the FDPX backbone. Consequently, as supported by earlier
tudies on the acid hydrolysis of sulfated polysaccharides [24], sul-
ate loss of FDPX occurred in our case. Seto et al. followed the
hemical shift changes in heparin undergoing desulfation by 1H
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Fig. 3. Representative 1H NMR  chemical shift changes (subplot A) of the FDPX 1H resonances upon titration of 3.4 mM FDPX solution with increasing portions of a 20.1 mM






Fig. 4. Titration profiles of the anomeric protons of the FDPX GlcNS6S and GlcNS3S
fitting assuming the FDPX·CD and the FDPX·2CD species are shown by red curves.
NMR  measurements [25]. Their result also supports our data, as
desulfation leads to downfield shift of particular resonances. The
largest 1H NMR  chemical shifts changes were observed in the case
of the IdoA2S and the trisulfated (GlcNS3S6S) subunits (Fig. S8),
suggesting that the sulfate loss primarily affected these units. Fur-







ts at pD 2.0. Blue curves were fitted by the 1:1 complexation model, while a global
To overcome the unwanted desulfation of FDPX in solution, the
ossible protective function of CD was  explored. To demonstrate
he stabilizing effect of the CD, 1H NMR  spectra of the freshly pre-
ared pD 2.0 samples with 1:0, 2:1 and 1:1 (FDPX:CD) molar ratios
ere recorded. All samples were incubated at 25 ◦C for a week,
hen 1H NMR  spectra were re-recorded. As shown in Fig. 6, almost
0% of the FDPX degraded in the absence of CD. The decompo-
ition process slowed down significantly in the presence of half
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Fig. 6. The 1H NMR spectra of the freshly prepared FDPX:CD samples (day 0) and t
1:0,  blue 2:1, green 1:1) under pD 2.0 conditions. The 1H resonances of the decomp
equivalent CD, as only 20% degradation could be observed by
1H NMR. However, samples of equimolar FDPX and CD however
revealed no detectable degradation of FDPX. Applying even higher
molar ratios of CD, complete protection of FDPX was  observed,
therefore, a minimum of equimolar CD is necessary to prevent
desulfation.
To accelerate the decomposition of FDPX, samples with the same
molar ratios were incubated at 60 ◦C for 14 h. 1H NMR  spectra
were registered prior and after the incubation at room tempera-
ture (Fig. S9). The sample without CD degraded completely, while
those containing CD exhibited less pronounced desulfation. In the
presence of 1:1 molar ratio minor degradation could be observed,






 the same samples stored at 25 ◦C for a week (day 7) at different molar ratios (red
 product are indicated by *.
.2. Studying FDPX degradation by nESI-MS
To study the complex formation between FDPX and CD
y MS-based methods, the compounds were dissolved in a
ater:methanol mixture (50/50, v/v) at a concentration of 20 M
or FDPX and 200 M for CD, yielding a 1:10 molar ratio. A repre-
entative mass spectrum obtained in negative ion mode is shown
n Fig. 7a (non-informative parts of the spectrum outside the m/z
ange of 400–1400 were omitted for clarity). No signal corre-
ponding to unbound FDPX could be detected, and the spectrum is
ominated by mass peaks of singly- and doubly-charged CD ions, as
ell as by triply- and quadruply-charged FDPX·CD complexes dis-
laying exclusively 1:1 stoichiometry. The assignment of species
long with m/z values reflecting monoisotopic masses are given in
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Fig. 7. Complex formation of fondaparinux and its degradation product with per-6-amino--cyclodextrin studied by nano-electrospray ionization mass spectrometry.
(A)  Negative ion mode nESI mass spectrum of a solution containing 20 M fondaparinux (FDPX) and 200 M per-6-amino--cyclodextrin (CD). Unbound CD ions and
corresponding mass peaks: [CD+2Cl + Na]− at m/z 1220.41; [CD + Cl]− at m/z 1162.45; [CD-H]− at m/z 1126.47; [CD+2Cl]2- at m/z  598.71 and [CD-2 H]2- at m/z 562.73.
CD:FDPX complex ions and respective mass peaks: [FDPX·CD-3 H]3- at m/z 877.14; [FDPX·CD-4 H]4- at m/z 657.6 and [FDPX·CD-5 H]5- at m/z  525.88. (B) Insets highlighting
diagnostic parts of the full mass spectrum shown at the top. The low extent of sulfate loss in the presence of CD is apparent: the intensity of mass peaks corresponding
to  [FDPX·CD-3H-SO3]3- at m/z 850.48 and [FDPX·CD-4H-SO3]4- at m/z 637.61 are roughly two orders of magnitude lower than those of the respective intact species. (C)
Diagnostic parts of negative ion mode nESI mass spectra of a solution containing fondaparinux degradation products (20 M),  spiked with 200 M CD. Dominant species
with  one to two  sulfate losses and the respective mass peaks: [FDPX·CD-3H+H3PO4-SO3]3− at m/z 883.14; [FDPX·CD-3H-SO3]3− at m/z  850.48; [FDPX·CD-3H-2SO3]3− at m/z
823.83;  [FDPX·CD-5H + Na-SO3]4− at m/z  643.11; [CD·FDPX-4H-SO3]4− at m/z 637.61 and [FDPX·CD-4H-2SO3]4− at m/z  617.62. Other major peaks not assigned in the figure











All  m/z values given above reflect monoisotopic masses.
the figure caption. The findings are in agreement with NMR  spec-
troscopic results, allowing for the confident determination of the
FDPX·CD complex stoichiometry based on orthogonal analytical
methods.
In general, highly-sulfated glycosaminoglycan (GAG) ions are
rather fragile in the gas phase: the loss of neutral SO3 (79.96 Da)
upon ion heating in the source or during collision induced dissoci-
ation is a dominant dissociation channel in MS-based experiments,
posing a major difficulty in the analysis of heparin and related
species [26–28]. Interestingly, the FDPX·CD complex remains pre-
dominantly intact upon transfer from solution to the gas phase. This
effect is analogous to the prevention of sulfate equivalent losses
by pairing highly-sulfated GAGs with basic arginine-rich peptides
in MS  experiments [29,30]. When electrospraying a solution of






bserved as shown exemplarily in Fig. 7b. The peaks corresponding
o [FDPX·CD-3H-SO3]3− and [FDPX·CD-4H-SO3]4- are weak, with
ntensities below 5% of those of the respective intact complexes.
he appearance of these minor peaks in the mass spectrum can be
xplained by two, mutually non-exclusive processes. Most proba-
ly, some loss of neutral SO3 occurs from the intact [FDPX·CD-3H]3−
nd [FDPX·CD-4H]4- ions during the MS  experiment. The other
ossibility is that partially degraded FDPX is already present in
olution, forming a complex with the cyclodextrin.
The stabilizing effect exerted by CD on the sulfate groups of
DPX not only facilitated the analysis of the intact FDPX·CD com-
lex, but also proved to be highly advantageous for the structural
haracterization of the fondaparinux degradation products.
MS  experiments were used to monitor the sulfate loss in FDPX
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ments samples were incubated as described in Section 2.3. Briefly,
a phosphate buffered pD 2.0 solution of 5 mM FDPX was incu-
bated at 60 ◦C for 14 h, diluted in water:methanol (50/50, v/v),
then spiked with the cationic cyclodextrin to reach a concentration
of 20 M for the FDPX degradation products (calculated for the
pre-degradation FDPX content) and 200 M for CD. Under experi-
mental conditions identical to those applied to record the spectrum
displayed in Fig. 7a and b (blue trace), markedly different mass
spectra were obtained for the sample containing FDPX degrada-
tion products, as highlighted in Fig. 7c (yellow trace). Owing to
potential differences in the ionization/ion transmission efficiency
of the various species, exact quantitative information may  not
be extracted from the MS  experiments. However, the dominance
of mass peaks corresponding to FDPX-related ions with sulfate
losses, such as [FDPX·CD-3H+H3PO4-SO3]3−, [FDPX·CD-3H-SO3]3−,
[FDPX·CD-3H-2SO3]3−, [FDPX·CD-5H + Na-SO3]4-, [FDPX·CD-4H-
SO3]4- and [FDPX·CD-4H-2SO3]4-, is clearly visible in the spectra
in Fig. 7c. Combining these results with the finding that CD com-
plexation efficiently hinders neutral loss of SO3 from FDPX in the
gas phase, we can conclude that the mass spectra reflect the com-
position of the solution and the distribution of species therein. That
is, the intense signals corresponding to the ions listed above are not
artefacts caused by gas-phase SO3 loss during the MS  experiment,
but instead correspond to degradation products already present in
solution.
In conclusion, results of MS  experiments support NMR  spec-
troscopic findings, enabling the unambiguous assignment of the
FDPX·CD complex stoichiometry. In addition, utilizing the bene-
ficial stabilizing effect of CD-complexation on the sulfate groups
of FDPX in the gas phase, MS  provides evidence that the degrada-
tion products of FDPX are pentasaccharides with an intact glycan
backbone, displaying predominantly one, and to a lesser extent two
sulfate losses.
4. Conclusions
In the present study, the intermolecular interactions of fonda-
parinux with heptakis(6-amino-6-deoxy)-beta-cyclodextrin were
characterized extensively by NMR  spectroscopy in solution and by
nESI-MS in the gas phase. NMR  spectroscopic studies revealed 1:1
stoichiometry and moderate affinity (log ˇ11 = 3.65 ± 0.02) at pD
7.4, while at pD 2.0 thermodynamically more stable species were
deduced: FDPX·CD (log ˇ11 ≥ 4.9 ± 0.1) and FDPX·2CD (log ˇ12 ≥ 8).
The possible interaction site involving the IdoA2S moiety and the
cationic part of the cyclodextrin has also been localized based on 2D
NMR studies. An in-depth characterization of the acidic degrada-
tion of FDPX by NMR  and MS  experiments suggested desulfation of
the pentasaccharide backbone at pD 2.0. Under these conditions,
the heptacationic cyclodextrin successfully prevents sulfate loss
by strong electrostatic interactions. Thus, our findings contribute
to a better understanding of heparin stabilization under acidic
conditions, offering an efficient method to prevent the unwanted
decomposition of heparinoids.
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